Ubs Group Ag Seagen Inc. Put Options Transaction History

Ubs Group Ag

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 09, 2023	BUY	$191.51 - $216.16 $133 Million - $150 Million	692,500 Added 323.3%	906,700 $192 Million
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $40.2 Million - $44.2 Million	214,200 New	214,200 $41.2 Million
Q2 2022 Aug 10, 2022	BUY	$108.81 - $179.33 $1.09 Million - $1.79 Million	10,000 New	10,000 $1.77 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.